title: Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy.
authors.forename: R
authors.initials: R
authors.lastname: Klingenberg
authors.forename: C
authors.initials: C
authors.lastname: Zugck
authors.forename: R
authors.initials: R
authors.lastname: Becker
authors.forename: D
authors.initials: D
authors.lastname: Schellberg
authors.forename: G
authors.initials: G
authors.lastname: Heinze
authors.forename: R
authors.initials: R
authors.lastname: Kell
authors.forename: A
authors.initials: A
authors.lastname: Remppis
authors.forename: W
authors.initials: W
authors.lastname: Schoels
authors.forename: H A
authors.initials: HA
authors.lastname: Katus
authors.forename: T J
authors.initials: TJ
authors.lastname: Dengler
mesh_terms: D015415:Biomarkers / Q000097:blood; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable; D005260:Female; D006333:Heart Failure / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000097:blood*; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D018579:Patient Selection; D013610:Tachycardia / Q000517:prevention & control*
chemical_list: D015415:Biomarkers; D020097:Natriuretic Peptide, Brain